Securities allotted from Block Listing

RNS Number : 0754R
The MedicX Fund Limited
18 September 2017
 

 

 

For immediate release

18 September 2017

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

 

Securities allotted from Block Listing

 

MedicX Fund Limited (LSE: MXF), announces in accordance with Listing Rule 3.5.6R the number of securities allotted over the six month period pursuant to the block listing of 23,981,109 ordinary shares of no par value admitted to The Official List of the UK Listing Authority on 16 September 2016.

 

Name of applicant:

MedicX Fund Limited

Name of scheme:

Block Listing

Period of return:

From:

19/03/2017

To:

18/09/2017

Balance of unallotted securities under scheme(s) from previous return:

18,500,217

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

14 August 2017 - 14,771,668

 

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

21/03/2017 - 2,000,000

04/04/2017 - 1,500,000

12/04/2017 - 1,500,000

13/04/2017 - 2,500,000

25/04/2017 - 500,000

26/04/2017 - 3,181,818

02/05/2017 - 1,500,000

03/05/2017 - 1,700,000

09/05/2017 - 1,850,000

18/05/2017 - 1,300,000

15/06/2017 - 968,399

Total allotted - 18,500,217

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

Total remaining - 14,771,668

 

Name of contact:

Alan Pennell

Telephone number of contact:

0203 142 4813

 

- End -

 

For further information please contact:

 

MedicX Fund                                                                  +44 (0) 1481 723 450

David Staples, Chairman

 

Octopus Healthcare Group                                               +44 (0) 20 3142 4820

Mike Adams, Chief Executive Officer

 

Canaccord Genuity                                                          +44 (0) 20 7523 8000

Andrew Zychowski/Helen Goldsmith        

 

Buchanan                                                                      +44 (0) 20 7466 5000

Charles Ryland/Vicky Hayns

 

Information on MedicX Fund Limited

 

MedicX Fund Limited ("MXF", "the Fund" or "the Company", or together with its subsidiaries, "the Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 156 properties.

 

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.comNeither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement. 

 

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRKMGMLDRZGNZM
UK 100

Latest directors dealings